Paul McGovern is an Infectious Disease physician affiliated with VenatoRx Pharmaceuticals. OpenAlex indexes 66 publications with 2,371 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
51 N 39th St
3910 Building, 2nd Floor
Philadelphia, PA 191042640
Telephone
215-662-9990Registry record last updated 2 Mar 2012.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pharmacokinetics and safety of single and repeat doses of ceftibuten in healthy participants: a phase 1 dose escalation study
Antimicrobial Agents and Chemotherapy
2025 - Plasma and intrapulmonary pharmacokinetics of cefepime and taniborbactam in healthy adult participants
Antimicrobial Agents and Chemotherapy
2025 - Safety and pharmacokinetics of single and multiple doses of ledaborbactam etzadroxil with or without ceftibuten in healthy volunteers
Antimicrobial Agents and Chemotherapy
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”